Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study
Photodermatology Photoimmunology & Photomedicine2019Vol. 35(5), pp. 332–338
Citations Over TimeTop 10% of 2019 papers
Liisa Väkevä, Sirkka Niemelä, Meri Lauha, Rafael Pasternack, Anna Hannuksela‐Svahn, Anna Hjerppe, Adrienn Joensuu, Minna Soronen, Lasse Ylianttila, Riikka Pastila, Hannu Kautiainen, Erna Snellman, M Grönroos, Toni Karppinen
Abstract
In psoriasis, narrowband UVB is a very efficient treatment in clinical setting, whereas in atopic dermatitis, more studies are needed to determine the best dosage.
Related Papers
- → IL‐31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis(2012)160 cited
- → Scoring atopic dermatitis and six sign atopic dermatitis: Comparison of prognostic and predictive value in atopic dermatitis(2013)5 cited
- → Assessment of the severity of atopic dermatitis — SCORAD and EASI(2022)3 cited
- → Serum OX40 ligand: a potential marker of atopic dermatitis disease severity in children(2009)2 cited
- Can the blood tryptase be an indicator of the severity of atopic dermatitis?(2020)